HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Price, J. Articles by Efthimiou, J. Search for Related Content PubMed PubMed Citation Articles by Price, J. Articles by Efthimiou, J.

Evaluating the effects of asthma therapy on childhood growth: principles of study design

¹ Department of Child Health, King's College, University of London, UK. ² Paediatric Endocrinology, The Middlesex Hospital, London, UK. ³ GlaxoSmithKline, Uxbridge, UK

CORRESPONDENCE: J.F. Price, Dept of Child Health, King's College Hospital, University of London, Denmark Hill, London, SE5 9RS, UK. Fax: 44 02073463657. E-mail: john.price@kcl.ac.uk

Keywords: asthma, child, corticosteroids, growth, research design

Received: May 31, 2001
Accepted January 12, 2002

Abstract

Inhaled corticosteroids have been established as the most effective treatment for childhood asthma. However, concerns persist regarding their potential effects on growth and, most importantly, final height.

To assess their effects on growth, inhaled corticosteroids can be compared with placebo (type 1 study), nonsteroidal anti-asthma therapy (type 2 study), another inhaled corticosteroid (type 3 study) or "real-life" anti-asthma therapy (type 4 study). Owing to the difficulties in obtaining final height data, several different surrogate measures have often been used: short-term lower leg growth, longer-term statural height growth velocity, childhood height and predicted final height.

This paper discusses the choice of end point, key trial design issues (including selection and number of subjects in the active and control populations) duration of assessments and methods for measuring height and data analysis, in the context of the different study types.

Specific study design recommendations have been developed after consideration of these factors, and these principles will be used to guide the interpretation of previously published growth studies.

This article has been cited by other articles:

				K-H. Carlsen and J. Gerritsen Inhaled steroids in children: adrenal suppression and growth impairment Eur. Respir. J., June 1, 2002; 19(6): 985 - 988. [Full Text] [PDF]

				J. Price, P. Hindmarsh, S. Hughes, and J. Efthimiou Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature? Eur. Respir. J., June 1, 2002; 19(6): 1179 - 1193. [Abstract] [Full Text] [PDF]